Sudden death after myocardial infarction - Who needs prophylaxis, and when?

被引:19
作者
Buxton, AE [1 ]
机构
[1] Lifespan Acad Med Ctr, Brown Med Sch, Dept Med, Div Cardiol, Providence, RI 02912 USA
关键词
D O I
10.1056/NEJMe058085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2638 / 2640
页数:3
相关论文
共 13 条
[1]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[2]  
Buxton AE, 2000, NEW ENGL J MED, V343, P1813
[3]   Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease - An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial [J].
Buxton, AE ;
Lee, KL ;
Hafley, GE ;
Wyse, DG ;
Fisher, JD ;
Lehmann, MH ;
Pires, LA ;
Gold, MR ;
Packer, DL ;
Josephson, ME ;
Prystowsky, EN ;
Talajic, MR .
CIRCULATION, 2002, 106 (19) :2466-2472
[4]  
DALY LE, 1987, BRIT HEART J, V58, P567
[5]   Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry [J].
Gorgels, APM ;
Gijsbers, C ;
de Vreede-Swagemakers, J ;
Lousberg, A ;
Wellens, HJJ .
EUROPEAN HEART JOURNAL, 2003, 24 (13) :1204-1209
[6]   Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction [J].
Hohnloser, SH ;
Kuck, KH ;
Dorian, P ;
Roberts, RS ;
Hampton, JR ;
Hatala, R ;
Fain, E ;
Gent, M ;
Connolly, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2481-2488
[7]   Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era [J].
Huikuri, HV ;
Tapanainen, JM ;
Lindgren, K ;
Raatikainen, P ;
Mäkikallio, TH ;
Airaksinen, KEJ ;
Myerburg, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :652-658
[8]   Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia [J].
Moss, AJ ;
Hall, WJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Klein, H ;
Levine, JH ;
Saksena, S ;
Waldo, AL ;
Wilber, D ;
Brown, MW ;
Heo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1933-1940
[9]   Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction [J].
Moss, AJ ;
Zareba, W ;
Hall, WJ ;
Klein, H ;
Wilber, DJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Brown, MW ;
Andrews, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :877-883
[10]   Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].
Pfeffer, MA ;
McMurray, JJV ;
Velazquez, EJ ;
Rouleau, JL ;
Kober, L ;
Maggioni, AP ;
Solomon, SD ;
Swedberg, K ;
Van de Werf, F ;
White, H ;
Leimberger, JD ;
Henis, M ;
Edwards, S ;
Zelenkofske, S ;
Sellers, MA ;
Califf, RM ;
Aylward, P ;
Armstrong, P ;
Barvik, S ;
Belenkov, Y ;
Dalby, A ;
Diaz, R ;
Drexler, H ;
Ertl, G ;
Francis, G ;
Hampton, J ;
Harsanyi, A ;
Kvasnicka, J ;
Mareev, V ;
Marin-Neto, J ;
Murin, J ;
Myers, M ;
Nordlander, R ;
Opolski, G ;
Soler-Soler, J ;
Spac, J ;
Stefenelli, T ;
Sugrue, D ;
Van Gilst, W ;
Varshavsky, S ;
Weaver, D ;
Zannad, F ;
Aguilar, D ;
Alvarez, A ;
Al-Taweel, M ;
Anavekar, N ;
Finn, P ;
Lopez-Jimenez, F ;
Mercier, R ;
Lewis, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906